ArticleEMBO reports2019

Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.

Amal M El-Naggar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.